221 related articles for article (PubMed ID: 12480604)
1. [Cyclosporin and portal venous inoculation of donor splenocytes prolongs cardiac allograft survival in mice].
Zhou HK; Yu LX; Zheng SB; Min ZL; Zhu YH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1093-5. PubMed ID: 12480604
[TBL] [Abstract][Full Text] [Related]
2. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
3. Experimental study of combined treatment with tacrolimus and donor splenocytes via the portal vein in small bowel transplantation.
Miyauchi T; Ishikawa M; Tashiro S; Hisaeda H; Himeno K
J Med Invest; 2001 Aug; 48(3-4):157-65. PubMed ID: 11694955
[TBL] [Abstract][Full Text] [Related]
4. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
[TBL] [Abstract][Full Text] [Related]
5. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival.
Kamei T; Callery MP; Flye MW
Surgery; 1990 Aug; 108(2):415-21; discussion 421-2. PubMed ID: 2382235
[TBL] [Abstract][Full Text] [Related]
6. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
7. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
Gao L; Woo J; Buelow R
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
[TBL] [Abstract][Full Text] [Related]
8. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Li J; Xia J; Zhang K; Xu L
J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
[TBL] [Abstract][Full Text] [Related]
9. Effects of portal venous inoculation with donor splenocytes on lung allograft survival in dogs.
Ichinari H; Shimizu T; Yoshioka M; Matsuzaki Y; Shibata K; Koga Y
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):300-5. PubMed ID: 8751494
[TBL] [Abstract][Full Text] [Related]
10. Liver sinusoidal endothelial cells contribute to alloreactive T-cell tolerance induced by portal venous injection of donor splenocytes.
Tokita D; Ohdan H; Onoe T; Hara H; Tanaka Y; Asahara T
Transpl Int; 2005 Feb; 18(2):237-45. PubMed ID: 15691278
[TBL] [Abstract][Full Text] [Related]
11. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
Tu Y; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
[TBL] [Abstract][Full Text] [Related]
12. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
Zhu XH; Chen S; Chen ZK
Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
[TBL] [Abstract][Full Text] [Related]
13. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
14. Effect of portal venous injection of donor spleen cells on skin allograft survival in rat.
Kara E; Gökhan I; Dayangaç M; Ilkgül O; Ertan H; Tokat Y; Terzioglu E
Indian J Med Res; 2004 Mar; 119(3):110-4. PubMed ID: 15115162
[TBL] [Abstract][Full Text] [Related]
15. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
Margenthaler JA; Landeros K; Kataoka M; Flye MW
Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
[TBL] [Abstract][Full Text] [Related]
17. A combination of donor specific transfusion and rapamycin prolongs cardiac allograft survival in mice.
Wu K; Xiang F; Yuan J; Zeng Z; Zhou H; Chang S; Chen ZK
Transplant Proc; 2008 Dec; 40(10):3699-701. PubMed ID: 19100468
[TBL] [Abstract][Full Text] [Related]
18. Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation.
Miyauchi T; Ishikawa M; Tashiro S; Hisaeda H; Nagasawa H; Himeno K
Transplantation; 1998 Jan; 65(1):27-32. PubMed ID: 9448139
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cardiac allograft survival by Vav1-Rac signaling blockade in a mouse model.
Wang S; Diao H; Guan Q; Jevnikar AM; Du C
Transpl Immunol; 2007 Jul; 18(1):53-61. PubMed ID: 17584603
[TBL] [Abstract][Full Text] [Related]
20. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
